To investigate the efficacy and advantages of the internal jugular-femoral-ascending aorta veno-venous-arterial extracorporeal membrane oxygenation (VV-A ECMO) mode in lung transplantation.
Clinical data of six high-risk lung transplant recipients (4 males, 2 females) who received intraoperative VV-A ECMO support between May 2025 and December 2025 were retrospectively analyzed, including general patient data, intraoperative cannulation strategy, changes of pulmonary artery pressure, blood loss, and postoperative ECMO mode conversion. All patients were evaluated as high-risk by a multidisciplinary team preoperatively.
All six patients successfully underwent lung transplantation with VV-A ECMO support, maintained stable intraoperative respiration and circulation, and were weaned from ECMO postoperatively. One patient died of hemorrhagic shock on postoperative day 10. The remaining five patients survived to 30 days postoperatively and were discharged successfully.
The application of VV-A ECMO mode in lung transplantation provides effective respiratory and circulatory support, reduces surgical risk and offers favorable clinical value.
京公网安备11010802044758号